BMS 181339: Clinical Trials

9 trials of BMS 181339, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 29Completed 9

Follow BMS 181339: new trials by email Literature Review of BMS 181339 trials Research Report on BMS 181339

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer
Ixabepilone, 32 mg/m^2, Paclitaxel, 200 mg/m^2, Carboplatin (area under the concentration curve [AUC] 6) - Advanced/Metastatic Non-Small Cell Lung Cancer
Phase 2CompletedR-Pharm2602008-12-012020-10-28
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer
Paclitaxel - Esophageal Cancer
Phase 2CompletedBristol-Myers Squibb12008-03-012013-07-26
A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer
Ixabepilone, 16 mg/m^2 + Bevacizumab, 10 mg/kg, Ixabepilone, 40 mg/m^2 + Bevacizumab, 15 mg/kg, Paclitaxel, 90 mg/m^2 + Bevacizumab, 10 mg/kg - Metastatic Breast Cancer
Phase 2CompletedR-Pharm1362007-03-012016-03-10
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer
Paclitaxel - Head and Neck Cancer
Phase 2CompletedBristol-Myers Squibb112006-08-042022-04-08
Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer
Paclitaxel - Head and Neck Cancer
Phase 2CompletedBristol-Myers Squibb362005-10-012010-02-04
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer
Paclitaxel - Breast Cancer
Phase 2CompletedBristol-Myers Squibb62005-06-302021-05-25
Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer
Paclitaxel - Head and Neck Cancer
Phase 2CompletedBristol-Myers Squibb362004-01-012011-04-25
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)
Paclitaxel - Non-Small Cell Lung Cancer
Phase 2CompletedBristol-Myers Squibb602002-12-012011-04-25
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer
Paclitaxel - Breast Cancer
Phase 2CompletedBristol-Myers Squibb682002-10-012010-02-04

Conditions studied

Breast Neoplasms (3)  ·  Head and Neck Neoplasms (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Esophageal Neoplasms (1)

Sponsors

Bristol-Myers Squibb (7)  ·  R-Pharm (2)

Countries

France (2)  ·  Italy (2)  ·  Japan (2)  ·  Spain (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Germany (1)  ·  Russia (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Results publications

PMID 23589560